$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Methods for fabricating polymer-based controlled release devices 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • B01J-013/02
  • B01J-013/04
  • A61K-009/22
출원번호 US-0935452 (1997-09-24)
발명자 / 주소
  • Tracy Mark A.
  • Herberger John D.
  • Burke Paul A.
  • Herbert Paul F.
출원인 / 주소
  • Alkermes Controlled Therapeutics, Inc.
대리인 / 주소
    Hamilton, Brook, Smith & Reynolds, P.C.
인용정보 피인용 횟수 : 188  인용 특허 : 26

초록

The present invention relates to a polymer-based sustained release device, and methods of forming and using the device for the sustained release of an active agent. The improved method of the invention for forming a polymer-bases sustained release device comprises forming a polymer/active agent solu

대표청구항

[ What is claimed is:] [1.] A method of forming a polymer-based sustained release device comprising the steps of:a) forming a polymer/biologically active agent solution by mixing a polymer, a continuous phase comprising one or more polymer solvents and a biologically active agent wherein the polymer

이 특허에 인용된 특허 (26)

  1. Yamada Minoru (Kawanishi JPX) Heya Toshiro (Takarazuka JPX) Ogawa Yasuaki (Otokuni-gun JPX), Biodegradable high-molecular polymers, production and use thereof.
  2. Dunn Richard L. (451 Boardwalk Dr. RLD ; Apt. 501 Fort Collins CO 80526) English James P. (2500 Melinda Cir. Birmingham AL 35214) Cowsar Donald R. (4657 Round Forest Dr. Birmingham AL 35213) Vanderbi, Biodegradable in-situ forming implants and methods of producing the same.
  3. Tracy Mark A. ; Bernstein Howard ; Khan M. Amin, Composition and method for the controlled release of metal cation-stabilized interferon.
  4. Johnson OluFunmi Lily (Cambridge MA) Ganmukhi Medha M. (Wexford PA) Bernstein Howard (Cambridge MA) Auer Henry (Belmont MA) Khan M. Amin (Dowington PA), Composition for sustained release of human growth hormone.
  5. Johnson OluFunmi Lily (Cambridge MA) Ganmukhi Medha M. (Wexford PA) Bernstein Howard (Cambridge MA) Auer Henry (Belmont MA) Khan M. Amin (Dowington PA), Composition for sustained release of human growth hormone.
  6. Zale Stephen E. (Hopkington MA) Burke Paul A. (Medford MA) Bernstein Howard (Cambridge MA) Brickner Avram (Brookline MA), Composition for sustained release of non-aggregated erythropoietin.
  7. Zale Stephen E. ; Burke Paul A. ; Bernstein Howard ; Brickner Avram, Composition for sustained release of non-aggregated erythropoietin.
  8. Tice Thomas R. (Birmingham AL) Lewis Danny H. (Gardendale AL) Cowsar Donald R. (Birmingham AL) Beck Lee R. (Birmingham AL), Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents.
  9. Tice, Thomas R.; Lewis, Danny H.; Cowsar, Donald R.; Beck, Lee R., Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents.
  10. Igari Yasutaka (Hyogo JPX) Saikawa Akira (Osaka JPX) Okamoto Kayoko (Osaka JPX) Kamei Shigeru (Hyogo JPX) Oka Masahisa (Kanagawa JPX) Sano Atsunori (Saitama JPX), Matrix for sustained-release preparation.
  11. Kobayashi Masao (Kyoto JPX) Nishioka Yukiko (Toyonaka JPX) Suzuki Takehiko (Toyono-gun JPX) Matsukawa Yashuhisa (Osaka JPX), Method for producing sustained release microsphere preparation.
  12. Kent John S. (Cupertino CA) Lewis Danny H. (Birmingham AL) Sanders Lynda M. (Palo Alto CA) Tice Thomas R. (Birmingham AL), Microencapsulation of water soluble active polypeptides.
  13. Tice Thomas R. (Helena AL) Lewis Danny H. (Gardendale AL), Microencapsulation process.
  14. Wantier Henri (Dour BEX) Mathieu Fabienne (Nivelles BEX) Baudrihaye Marc (Waterloo BEX) Delacroix Dominique (Kraainem BEX), Microspheres for the controlled release of water-soluble substances and process for preparing them.
  15. Bernstein Howard (Cambridge MA) Zhang Yan (Cambridge MA) Khan M. Amin (Downingtown PA) Tracy Mark A. (Arlington MA), Modulated release from biocompatible polymers.
  16. Wunderlich Jens-Christian (Heidelberg DEX) Schick Ursula (Wiesloch DEX) Freidenreich Jurgen (Schriesheim DEX) Werry Jurgen (Ludwigshafen DEX), Pellets containing plant extracts, process of making same and their pharmaceutical peroral or cosmetic use.
  17. Yamamoto Masaki (Osaka JPX) Okada Hiroaki (Osaka JPX) Ogawa Yasuaki (Osaka JPX) Miyagawa Tsutomu (Saitama JPX), Polymer, production and use thereof.
  18. DeLuca Patrick P. (Lexington KY) Kanke Motoko (Fukuyama JPX) Sato Toyomi (Tokyo CA JPX) Schroeder Hans G. (Encinitas CA), Porous microspheres for drug delivery and methods for making same.
  19. Ramstack J. Michael (Lebanon OH) Herbert Paul F. (Wayland MA) Strobel Jan (Westchester OH) Atkins Thomas J. (Cincinnati OH), Preparation of biodegradable microparticles containing a biologically active agent.
  20. Wantier Henri (Dour BEX) Mathieu Fabienne (Nivelles BEX) Baudrihaye Marc (Waterloo BEX) Delacroix Dominique (Kraainem BEX), Preparation of microparticles for controlled release of water-soluble substances.
  21. Tice Thomas R. (Birmingham AL) Orsolini Piero (Martigny LA CHX) Schally Andrew V. (New Orleans LA), Process for increasing the antagonistic effect of peptidic compounds on hormone-dependent diseases.
  22. Billot Genevieve B. (Lyons FRX) Teichner Marc M. (Sainte Foy Les Lyon FRX), Process for preparing microspheres for the prolonged release of the LHRH hormone and its analogues, microspheres and for.
  23. Fong Jones W. (Parsippany NJ), Processes for preparation of microspheres.
  24. Lokensgard David M. (San Jose CA), Solvent extraction process.
  25. Orsolini Piero (Martigny) Mauvernay Rolland-Yves (Lausanne) Deghenghi Romano (Lausanne CHX), Sustained and controlled release of water insoluble polypeptides.
  26. Gombotz Wayne R. (Lexington MA) Healy Michael S. (E. Bridgewater MA) Brown Larry R. (Newton MA), Very low temperature casting of controlled release microspheres.

이 특허를 인용한 특허 (188)

  1. Barghorn, Stefan; Hillen, Heinz; Striebinger, Andreas R.; Labkovsky, Boris; Ebert, Ulrich; Keller, Patrick, Abeta conformer selective anti-Abeta globulomer monoclonal antibodies.
  2. Hillen, Heinz; Striebinger, Andreas; Krantz, Carsten; Moeller, Achim; Mueller, Reinhold, Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof.
  3. Barghorn, Stefan; Hillen, Heinz; Striebinger, Andreas; Giaisi, Simone; Ebert, Ulrich; Benatuil, Lorenzo, Amyloid-beta binding proteins.
  4. Barghorn, Stefan; Hillen, Heinz; Striebinger, Andreas; Giaisi, Simone; Ebert, Ulrich; Benatuil, Lorenzo, Amyloid-beta binding proteins.
  5. Barghorn, Stefan; Hillen, Heinz; Striebinger, Andreas; Giaisi, Simone; Ebert, Ulrich; Hsieh, Chung-Ming, Amyloid-beta binding proteins.
  6. Barghorn, Stefan; Hillen, Heinz; Striebinger, Andreas; Giaisi, Simone; Ebert, Ulrich; Hsieh, Chung-Ming, Amyloid-beta binding proteins.
  7. Hillen, Heinz; Barghorn, Stefan; Labkovsky, Boris; Ebert, Ulrich; Striebinger, Andreas R.; Keller, Patrick, Amyloid-beta globulomer antibodies.
  8. Coy, David H.; Maderdrut, Jerome L.; Li, Min, Analogs of pituitary adenylate cyclase-activating polypeptide (PACAP) and methods for their use.
  9. Barghorn, Stefan; Hillen, Heinz; Labkovsky, Boris; Striebinger, Andreas R.; Keller, Patrick; Ebert, Ulrich, Anti-Aβ globulomer 5F7 antibodies.
  10. Barghorn, Stefan; Hillen, Heinz; Labkovsky, Boris; Striebinger, Andreas R.; Keller, Patrick; Ebert, Ulrich, Anti-Aβ globulomer 7C6 antibodies.
  11. Lippincott, John; Van Der Horst, Edward Thein Htun; Kim, Sun Young; Presta, Leonard G., Anti-C10orf54 antibodies and uses thereof.
  12. Patz, Jr., Edward F.; Campa, Michael J.; Gottlin, Elizabeth; Haynes, Barton F.; Liao, Hua-Xin; Moody, Anthony M., Anti-Complement factor H antibodies.
  13. Gu, Jijie; Ambrosi, Dominic J.; Lappe, Susan E.; Li, Yingchun; Hickson, Jonathan A.; Haasch, Deanna L.; Gupta, Supriya; Chari, Ravi; Zamiri, Camellia; Naumovski, Louie; Cao, Xianhua, Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof.
  14. Gu, Jijie; Ambrosi, Dominic J.; Lappe, Susan E.; Li, Yingchun; Hickson, Jonathan A.; Haasch, Deanna L.; Gupta, Supriya; Chari, Ravi; Zamiri, Camellia; Naumovski, Louie; Cao, Xianhua, Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof.
  15. Gu, Jijie; Ambrosi, Dominic J.; Lappe, Susan E.; Li, Yingchun; Hickson, Jonathan A.; Haasch, Deanna L.; Gupta, Supriya; Chari, Ravi; Zamiri, Camellia; Naumovski, Louie; Cao, Xianhua, Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof.
  16. Tu, Bailin; Ziemann, Robert N.; Tieman, Bryan C.; Hemken, Philip M.; Ramsay, Carol S.; Strobel, Carolyn J.; Hawksworth, David J.; Birkenmeyer, Larry G.; Zhao, Cheng; Brophy, Susan E.; Dowell, Barry L.; Muerhoff, Anthony S., Anti-GP73 monoclonal antibodies and methods of obtaining the same.
  17. Lacy, Susan E.; Barbon, Jeffrey A.; Chhaya, Meha; Fung, Emma; Hutchins, Charles W.; Lang, Diane M.; Barlow, Eve H.; Leddy, Mary; Chari, Ravi, Anti-NGF antibodies and their use.
  18. Lacy, Susan E.; Barbon, Jeffrey A.; Chhaya, Meha; Fung, Emma; Hutchins, Charles W.; Lang, Diane M.; Barlow, Eve H.; Leddy, Mary; Chari, Ravi, Anti-NGF antibodies and their use.
  19. Young, James F.; Koenig, Scott; Johnson, Leslie S., Anti-RSV antibodies.
  20. Williamson, Robert Anthony; Wadia, Jehangir; Pascual, Gabriel; Keogh, Elissa, Anti-human Respiratory Syncytial Virus (RSV) antibodies and methods of use.
  21. Williamson, Robert Anthony; Wadia, Jehangir; Pascual, Gabriel; Keogh, Elissa, Anti-human respiratory syncytial virus (RSV) antibodies and methods of use.
  22. Williamson, Robert Anthony; Wadia, Jehangir; Pascual, Gabriel; Keogh, Elissa, Anti-human respiratory syncytial virus (RSV) antibodies and methods of use.
  23. Austen John Woolfe GB; Siobhan Greene IE; Gordon McIntyre GB; Nitin Vadilal Sheth, Anti-inflammatory pharmaceutical formulations.
  24. Woolfe, Austen John; Greene, Siobhan; McIntyre, Gordon; Sheth, Nitin Vadilal, Anti-inflammatory pharmaceutical formulations.
  25. Woolfe, Austen John; Greene, Siobhan; McIntyre, Gordon; Sheth, Nitin Vadilal, Anti-inflammatory pharmaceutical formulations.
  26. Woolfe, Austen John; McIntyre, Gordon; Sheth, Nitin Vadilal, Anti-inflammatory pharmaceutical formulations.
  27. McAuliffe, Josephine; Palmer-Hill, Frances; Zhu, Qing; Suzich, JoAnn, Antibodies against and methods for producing vaccines for respiratory syncytial virus.
  28. McAuliffe, Josephine; Palmer-Hill, Frances; Zhu, Qing; Suzich, Joann, Antibodies against and methods for producing vaccines for respiratory syncytial virus.
  29. Williamson, Robert Anthony; Wadia, Jehangir; Pascual, Gabriel; Keogh, Elissa, Antibodies against human respiratory syncytial virus (RSV) and methods of use.
  30. Williamson, Robert Anthony; Wadia, Jehangir; Pascual, Gabriel; Keogh, Elissa, Antibodies against human respiratory syncytial virus (RSV) and methods of use.
  31. Gu, Jijie; Bowley, Diana; Eaton, Lucia; Dong, Feng; Benatuil, Lorenzo; Ghayur, Tariq; Chari, Ravi; Rieser, Matthew; Clabbers, Anca, Antibodies against platelet-derived growth factor (PDGF).
  32. Mueller, Bernhard K.; Schmidt, Martin; Barlow, Eve; Leddy, Mary; Hsieh, Chung-Ming; Bardwell, Philip, Antibodies against the RGM A protein and uses thereof.
  33. Mueller, Bernhard K.; Schmidt, Martin; Barlow, Eve; Leddy, Mary; Hsieh, Chung-Ming; Bardwell, Philip, Antibodies against the RGM a protein and uses thereof.
  34. Yoshimura, Toru; Dowell, Barry Lee; Beligere, Gangamani S.; Yoshida, Eisaku, Antibodies relating to PIVKA-II and uses thereof.
  35. Yoshimura, Toru; Dowell, Barry L.; Beligere, Gangamani S.; Ruan, Qiaoqiao, Antibodies relating to PIVKAII and uses thereof.
  36. Mueller, Bernhard; Huang, Lili; Bardwell, Philip D.; Kutskova, Yuliya; Memmott, John, Antibodies that bind to repulsive guidance molecule A (RGMA).
  37. Strakhova, Marina I.; Brederson, Jill-Desiree, Antibodies to receptor for advanced glycation end products (RAGE) and uses thereof.
  38. Strakhova, Marina I.; Brederson, Jill-Desiree, Antibodies to receptor for advanced glycation end products (RAGE) and uses thereof.
  39. Gu, Jijie; Hsieh, Chung-Ming; Wu, Zhen; DiGiammarino, Enrico L.; Luo, Feng; Fox, Gerard B.; Harlan, John E.; Schmidt, Martin; Loebbert, Ralf; Mueller, Reinhold; Ebert, Ulrich; Nimmrich, Volker, Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof.
  40. Gu, Jijie; Hsieh, Chung-Ming; Wu, Zhen; DiGiammarino, Enrico L.; Luo, Feng; Fox, Gerard B.; Harlan, John E.; Schmidt, Martin; Loebbert, Ralf; Mueller, Reinhold; Ebert, Ulrich; Nimmrich, Volker, Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof.
  41. Brophy, Susan E.; Tu, Bailin; Huang, Dagang; Tyner, Joan D.; Ziemann, Robert N., Antibodies to troponin I and methods of use thereof.
  42. Brophy, Susan E.; Tu, Bailin; Tyner, Joan D.; Tyner, legal representative, Lowell J.; Huang, Dagang; Ziemann, Robert N., Antibodies to troponin I and methods of use thereof.
  43. Barghorn, Stefan; Hillen, Heinz; Striebinger, Andreas R.; Labkovsky, Boris; Ebert, Ulrich; Keller, Patrick, Aβ conformer selective anti-Aβ globulomer monoclonal antibodies.
  44. Barghorn, Stefan; Hillen, Heinz; Striebinger, Andreas R.; Labkovsky, Boris; Ebert, Ulrich; Keller, Patrick, Aβ conformer selective anti-Aβ globulomer monoclonal antibodies.
  45. Barghorn, Stefan; Hillen, Heinz; Striebinger, Andreas R.; Labkovsky, Boris; Ebert, Ulrich; Keller, Patrick, Aβ conformer selective anti-Aβ globulomer monoclonal antibodies.
  46. Barghorn, Stefan; Hillen, Heinz; Striebinger, Andreas R.; Labkovsky, Boris; Ebert, Ulrich; Keller, Patrick, Aβ conformer selective anti-aβ globulomer monoclonal antibodies.
  47. Falb, Dean; Isabella, Vincent M.; Kotula, Jonathan W.; Miller, Paul F.; Millet, Yves; Rowe, Sarah, Bacteria engineered to reduce hyperphenylalaninemia.
  48. Falb, Dean; Isabella, Vincent M.; Kotula, Jonathan W.; Miller, Paul F.; Rowe, Sarah; Millet, Yves, Bacteria engineered to reduce hyperphenylalaninemia.
  49. Falb, Dean; Isabella, Vincent M.; Kotula, Jonathan W.; Miller, Paul F., Bacteria engineered to treat diseases associated with hyperammonemia.
  50. Falb, Dean; Isabella, Vincent M.; Kotula, Jonathan W.; Miller, Paul F.; Machinani, Suman, Bacteria engineered to treat diseases associated with hyperammonemia.
  51. Bonvini, Ezio; Johnson, Leslie S.; Huang, Ling; Moore, Paul A.; Chichili, Gurunadh Reddy; Alderson, Ralph Froman, Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses thereof.
  52. Moore, Paul A.; Li, Jonathan; Chen, Francine Zhifen; Johnson, Leslie S.; Shah, Kalpana; Bonvini, Ezio, Bi-specific monovalent diabodies that are capable of binding to gpA33 and CD3, and uses thereof.
  53. Muller, Bernhard K.; Schaffar, Gregor; Mueller, Reinhold, Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use.
  54. Bergeron, Lisa Marie; Bainbridge, Graeme; Dunham, Steven A.; Dai, Minghua, Caninized anti-NGF antibodies and methods thereof.
  55. Bergeron, Lisa Marie; Bainbridge, Graeme; Dunham, Steven; Dai, Minghua, Caninized anti-NGF antibodies and methods thereof.
  56. Lacy, Susan E.; Barbon, Jeffrey A.; Chhaya, Meha; Fung, Emma; Hutchins, Charles W.; Lang, Diane M.; Barlow, Eve H.; Leddy, Mary; Chari, Ravi, Caninized anti-NGF antibodies and their use.
  57. Mueller, Bernhard; Huang, Lili; Bardwell, Philip D.; Kutskova, Yuliya; Memmott, John, Composition and method for the diagnosis and treatment of diseases associated with neurite degeneration.
  58. Beligere, Gangamani S.; Manoj, Shamila; Brate, Elaine M.; Grenier, Frank C.; Hawksworth, David J.; Ziemann, Robert N.; Birkenmeyer, Larry G.; Mueller, Bernhard; Popp, Andreas; Brophy, Susan, Composition and method for the diagnosis and treatment of iron-related disorders.
  59. Mueller, Bernhard; Popp, Andreas; Perez, Jennifer M., Composition and method for the diagnosis and treatment of iron-related disorders.
  60. Everland, Hanne; Samuelsen, Peter; Vange, Jakob; Clausen, Christian; Gallego, Monica Ramos, Compositions and methods for augmentation and regeneration of living tissue in a subject.
  61. Leung, Karling Alice, Compositions, devices and methods of use thereof for the treatment of cancers.
  62. Li, Jianmin; Bucay Couto, Weenna, Controlled drug delivery.
  63. Bonvini, Ezio; Johnson, Leslie S.; Shah, Kalpana; La Motte-Mohs, Ross; Moore, Paul A.; Koenig, Scott, Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereof.
  64. Asgarzadeh, Firouz; Costantino, Henry R., Crosslinked hydrogel copolymers.
  65. Freyman, Toby, Decellularized bone marrow extracellular matrix.
  66. Freyman,Toby, Decellularized bone marrow extracellular matrix.
  67. Shastri, Venkatram P., Degradable polymers from derivatized ring-opened epoxides.
  68. Brown, Larry R.; Bisker-Leib, Vered; Scott, Terrence L.; Lafreniere, Debra; Machen, Jennifer; Giannoukakis, Nick, Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes.
  69. Brown, Larry R.; Bisker-Leib, Vered; Scott, Terrence L.; Lafreniere, Debra; Machen, Jennifer; Giannoukakls, Nick, Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes.
  70. Siegel, Steven; Winey, Karen, Drug-containing implants and methods of use thereof.
  71. Siegel, Steven; Winey, Karen, Drug-containing implants and methods of use thereof.
  72. Siegel, Steven; Winey, Karen, Drug-containing implants and methods of use thereof.
  73. Ghayur, Tariq; Gu, JiJie; Harris, Maria; Goodreau, Carrie; Saluja, Sonal, Dual specific binding proteins directed against IL-1 and/or IL-17.
  74. Hsieh, Chung-Ming; Ghayur, Tariq; Goodreau, Carrie L., Dual specific binding proteins directed against IL-13 and IL-17.
  75. Ghayur, Tariq; Gu, JiJie; Harris, Maria; Goodreau, Carrie; Saluja, Sonal, Dual specific binding proteins directed against IL-1β and/or IL-17.
  76. Wu, Chengbin; Ghayur, Tariq; Dixon, Richard W.; Salfeld, Jochen G., Dual variable domain immunoglobulin and uses thereof.
  77. Ghayur, Tariq; Hahn, Alfred; Mueller, Bernhard, Dual variable domain immunoglobulins and uses thereof.
  78. Ghayur, Tariq; Isakson, Peter C.; Olson, Lisa M.; Wu, Chengbin; Hugunin, Margaret; Kamath, Rajesh V.; Cuff, Carolyn A.; Allen, Hamish J., Dual variable domain immunoglobulins and uses thereof.
  79. Ghayur, Tariq; Kamath, Rajesh V.; Liu, Junian; Honore, Marie P., Dual variable domain immunoglobulins and uses thereof.
  80. Ghayur, Tariq; Liu, Junjian; Isakson, Peter C., Dual variable domain immunoglobulins and uses thereof.
  81. Ghayur, Tariq; Liu, Junjian; Isakson, Peter C., Dual variable domain immunoglobulins and uses thereof.
  82. Ghayur, Tariq; Liu, Junjian; Manoj, Sharmila; Brophy, Susan E., Dual variable domain immunoglobulins and uses thereof.
  83. Ghayur, Tariq; Morgan-Lappe, Susan E.; Reilly, Edward B.; Kingsbury, Gillian A.; Phillips, Andrew; Wang, Jieyi; Bell, Randy L.; Norvell, Suzanne M.; Li, Yingchun; Liu, Junjian; Ying, Hua, Dual variable domain immunoglobulins and uses thereof.
  84. Ghayur, Tariq; Salfeld, Jochen G.; McPherson, Michael J., Dual variable domain immunoglobulins and uses thereof.
  85. Ghayur, Tariq; Salfeld, Jochen G.; McPherson, Michael J.; Harris, Maria C.; Liu, Junjian; Isakson, Peter C.; Gu, Jijie, Dual variable domain immunoglobulins and uses thereof.
  86. Kim, Kyekyoon; Singh, Ravindra Pratap, Electrohydrodynamic spraying system.
  87. Muerhoff, A. Scott; Marohnic, Christopher; Birkenmeyer, Larry; Prostko, John; Bogdan, M. Felisha; Gutierrez, Robin, HCV NS3 recombinant antigens and mutants thereof for improved antibody detection.
  88. Dawson, George J.; Desai, Suresh M.; Gutierrez, Robin A.; Muerhoff, A. Scott; Prostko, John; Bogdan, M. Felicia; Marohnic, Christopher C., HCV antigen-antibody combination assay and methods and compositions for use therein.
  89. Ziemann, Robert; Ahlberg, April; Hawksworth, David; Tieman, Bryan; Muerhoff, A. Scott; Marohnic, Christopher; Otis, Kathy, HCV core lipid binding domain monoclonal antibodies.
  90. Ziemann, Robert; Ahlberg, April; Hawksworth, David; Tieman, Bryan; Muerhoff, A. Scott; Marohnic, Christopher; Otis, Kathy, HCV core lipid binding domain monoclonal antibodies.
  91. Young, James F.; Johnson, Leslie S.; Huse, William D.; Wu, Herren; Watkins, Jeffry D., High potency recombinant antibodies and method for producing them.
  92. Young, James F.; Johnson, Leslie S.; Huse, William D.; Wu, Herron; Watkins, Jeffrey D., High potency recombinant antibodies and method for producing them.
  93. Hsieh, Chung-ming; Wu, Chengbin, IL-1 binding proteins.
  94. Lacy, Susan E.; Benatuil, Lorenzo; Chhaya, Meha; Fung, Emma; Miller, Renee; Chari, Ravi; Heighton, Sarah J.; Bixby, Jacqueline G., IL-1 binding proteins.
  95. Wu, Chengbin; Ambrosi, Dominic J.; Hsieh, Chung-ming; Ghayur, Tariq, IL-1 binding proteins.
  96. Wu, Chengbin; Ambrosi, Dominic J.; Hsieh, Chung-ming; Ghayur, Tariq, IL-1 binding proteins.
  97. Wu, Chengbin; Ambrosi, Dominic J.; Hsieh, Chung-ming; Ghayur, Tariq, IL-1 binding proteins.
  98. Wu, Chengbin; Ambrosi, Dominic J.; Hsieh, Chung-ming; Ghayur, Tariq, IL-1 binding proteins.
  99. Wu, Chengbin; Ambrosi, Dominic J.; Hsieh, Chung-ming; Ghayur, Tariq, IL-1 binding proteins.
  100. Wu, Chengbin; Ambrosi, Dominic J.; Hsieh, Chung-ming; Ghayur, Tariq, IL-1 binding proteins.
  101. Lacy, Susan E.; Fung, Emma; Belk, Jonathan P.; Dixon, Richard W.; Roguska, Michael; Hinton, Paul R.; Kumar, Shankar, IL-12/p40 binding proteins.
  102. Lacy, Susan E.; Fung, Emma; Belk, Jonathan P.; Dixon, Richard W.; Roguska, Michael; Hinton, Paul R.; Kumar, Shankar, IL-12/p40 binding proteins.
  103. Hsieh, Chung-Ming; Hugunin, Margaret; Kutskova, Yuliya; Memmott, John E.; Perez, Jennifer M.; Zhong, Suju; Tarcsa, Edit; Clabbers, Anca, IL-17 binding proteins.
  104. Hsieh, Chung-Ming; Hugunin, Margaret; Murtaza, Anwar; McRae, Bradford L.; Kutskova, Yuliya; Memmott, John E.; Perez, Jennifer M.; Zhong, Suju; Tarcsa, Edit; Clabbers, Anca; Wallace, Craig; Bryant, Shaughn H.; Leddy, Mary R., IL-17 binding proteins.
  105. Hsieh, Chung-Ming; Hugunin, Margaret; Murtaza, Anwar; McRae, Bradford L.; Kutskova, Yuliya; Memmott, John E.; Perez, Jennifer M.; Zhong, Suju; Tarcsa, Edit; Clabbers, Anca; Wallace, Craig; Bryant, Shaughn H.; Leddy, Mary R., IL-17 binding proteins.
  106. Hsieh, Chung-Ming; Hugunin, Margaret; Murtaza, Anwar; McRae, Bradford L.; Kutskova, Yuliya; Memmott, John E.; Perez, Jennifer M.; Zhong, Suju; Tarcsa, Edit; Clabbers, Anca; Wallace, Craig; Bryant, Shaughn H.; Leddy, Mary R., IL-17 binding proteins.
  107. Hsieh, Chung-Ming; Hugunin, Margaret; Murtaza, Anwar; McRae, Bradford L.; Kutskova, Yuliya; Memmott, John E.; Perez, Jennifer M.; Zhong, Suju; Tarcsa, Edit; Clabbers, Anca; Wallace, Craig; Bryant, Shaughn H.; Leddy, Mary R., IL-17 binding proteins.
  108. Wu, Chengbin; Ambrosi, Dominic J.; Hsieh, Chung-ming; Ghayur, Tariq, IL-I binding proteins.
  109. Smith, Jay S.; Cole, Michael R.; Whitson, Amy K., Implant placement guide.
  110. Smith, Jay S.; Cole, Michael R.; Whitson, Amy K., Implant placement guide.
  111. Li, Jianmin; Conley, Danielle; Bucay-Couto, Weenna; Dao, Cang Duy; Davoudi, Hamid; Lareau, Raymond J.; Miller, Kathleen M, Implantable or insertable medical devices for controlled drug delivery.
  112. Li, Jianmin; Conley, Danielle; Couto, Weenna Bucay; Dao, Cang Duy; Davoudi, Hamid; Lareau, Raymond; Miller, Kathleen M., Implantable or insertable medical devices for controlled drug delivery.
  113. Markland, Peter; Winchester, Gary Anthony; Tice, Thomas Robert; Martin, David P., Injectable delivery of microparticles and compositions therefore.
  114. Wu, Chengbin; Dixon, Richard W.; Belk, Jonathan P.; Argiriadi, Maria A.; Ying, Hua; Cuff, Carolyn A.; Melim, Terry L.; Kumar, Shankar; Hinton, Paul R.; Chen, Yan, Interleukin-13 binding proteins.
  115. Wu, Chengbin; Dixon, Richard W.; Belk, Jonathan P.; Argiriadi, Maria A.; Ying, Hua; Cuff, Carolyn A.; Melim, Terry L.; Kumar, Shankar; Hinton, Paul R.; Chen, Yan, Interleukin-13 binding proteins.
  116. Wu, Chengbin; Dixon, Richard W.; Belk, Jonathan P.; Ying, Hua; Argiriadi, Maria A.; Cuff, Carolyn A.; Hinton, Paul R.; Kumar, Shankar; Melim, Terry L.; Chen, Yan, Interleukin-13 binding proteins.
  117. Mueller, Bernhard; Huang, Lili; Bardwell, Philip D.; Kutskova, Yuliya; Memmott, John, Isolated monoclonal anti-repulsive guidance molecule A antibodies and uses thereof.
  118. Benatuil, Lorenzo; Deng, Kangwen; Hanzatian, Denise Karaoglu; Argiriadi, Maria A., LRP-8 binding dual variable domain immunoglobulin proteins.
  119. Bucay-Couto, Weenna, Medical imaging reference devices.
  120. Nimmrich, Volker; Barghorn, Stefan; Ebert, Ulrich; Hillen, Heinz; Gross, Gerhard; Draguhn, Andreas; Bruhl, Claus; Grimm, Christine; Krantz, Carsten, Method for the treatment of amyloidoses.
  121. Siegel, Steven; Winey, Karen, Method of maintaining therapeutic risperidone levels in a PLA:PLGA implant.
  122. Mark A. Tracy ; John D. Herberger ; Paul A. Burke ; Paul F. Herbert, Methods for fabricating polymer-based controlled release devices.
  123. Brown, Larry; McGeehan, John K.; Rashba-Step, Julia; Scott, Terrence L., Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation.
  124. Chi, Andrew S., Methods for the treatment of vascularizing cancers.
  125. Young, James F.; Koenig, Scott; Johnson, Leslie S.; Huse, William D.; Watkins, Jeffrey D., Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment.
  126. Young, James F.; Koenig, Scott; Johnson, Leslie S.; Huse, William D.; Watkins, Jeffrey D.; Wu, Herren, Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment.
  127. Young, James F.; Koenig, Scott; Johnson, Leslie S.; Huse, William D.; Watkins, Jeffrey D.; Wu, Herren, Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment.
  128. Young, James F.; Koenig, Scott; Johnson, Leslie S.; Huse, William D.; Watkins, Jeffrey D.; Wu, Herren, Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment.
  129. Young,James F.; Koenig,Scott; Johnson,Leslie S.; Huse,William D.; Watkins,Jeffrey D.; Wu,Herren, Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment.
  130. Young,James F.; Koenig,Scott; Johnson,Leslie S.; Huse,William D.; Watkins,Jeffrey D.; Wu,Herren, Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment.
  131. Young,James F.; Koenig,Scott; Johnson,Leslie S.; Huse,William D.; Watkins,Jeffrey D.; Wu,Herren, Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment.
  132. Darvari, Ramin; Lambert, Adam; Rashba-Step, Julia E.; Yang, Mark X.; Zhang, Junhong; O'Connell, Ed, Methods of processing compositions containing microparticles.
  133. Piran, Uri; Mehr, Eugene; Brown, Larry R.; McGeehan, John K.; O'Connell, Ed, Methods of processing compositions containing microparticles.
  134. Piran, Uri, Methods of processing multi-phasic dispersions.
  135. Mueller, Bernhard K., Methods of treating retinal nerve fiber layer degeneration with monoclonal antibodies against a retinal guidance molecule (RGM) protein.
  136. Kim, Kyekyoon; Choi, Hyungsoo; Choy, Young Bin, Microparticles.
  137. Kim, Kyekyoon; Pack, Daniel W.; Berkland, Cory, Microparticles.
  138. Kim,Kyekyoon; Choi,Hyungsoo; Choy,Young Bin, Microparticles.
  139. Kim,Kyekyoon; Pack,Daniel W.; Berkland,Cory, Microparticles.
  140. Brown, Larry R.; Giannoukakis, Nick; Gillis, Kimberly A.; Trucco, Massimo, Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes.
  141. Hillen, Heinz; Barghorn, Stefan; Labkovsky, Boris; Ebert, Ulrich; Striebinger, Andreas R.; Keller, Patrick, Monoclonal antibodies against amyloid beta protein and uses thereof.
  142. Ishihara, Tsutomu; Mizushima, Yutaka, Nanoparticles containing water-soluble non-peptide low-molecular weight drug.
  143. Brown, Larry R.; Scott, Terrence L.; Lafreniere, Debra; Bisker-Leib, Vered, Nucleic acid microspheres, production and delivery thereof.
  144. Scott, Terrence; Lafreniere, Debra; Bisker-Leib, Vered; Brown, Larry, Nucleic acid microspheres, production and delivery thereof.
  145. Siegel, Steven J.; Winey, Karen I.; Gur, Raquel E.; Lenox, Robert H., Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use.
  146. Siegel, Steven J.; Winey, Karen I.; Gur, Raquel E.; Lenox, Robert H., Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use.
  147. Wright, Steven G.; Christensen, Troy; Yeoh, Thean; Rickey, Michael E.; Hotz, Joyce M.; Kumar, Rajesh; Costantino, Henry R., Polymer-based sustained release device.
  148. Wright, Steven G.; Christensen, Troy; Yeoh, Thean; Rickey, Michael E.; Hotz, Joyce M.; Kumar, Rajesh; Costantino, Henry R., Polymer-based sustained release device.
  149. Wright, Steven G.; Christensen, Troy; Yeoh, Thean; Rickey, Michael E.; Hotz, Joyce M.; Kumar, Rajesh; Fineman, Mark; Smith, Christine; Ong, John; Lokensgard, David M.; Costantino, Henry R., Polymer-based sustained release device.
  150. Gupta, Kavita; Clark, Meredith R.; Kiser, Patrick F.; Jay, Julie I., Polymeric compositions and methods of making and using thereof.
  151. Biggs, Danielle; Nettles, Heather, Process for preparing microparticles having a low residual solvent volume.
  152. Brown,Larry R., Production of microspheres.
  153. Ghayur, Tariq; Gu, Jijie; Isakson, Peter C., Prostaglandin E2 dual variable domain immunoglobulins and uses thereof.
  154. Brown, Larry; Bisker-Leib, Vered; LaFreniere, Debra; McGeehan, John; Rashba-Step, Julia; Scott, Terrence, Protein microspheres having injectable properties at high concentrations.
  155. Brown, Larry R.; Yang, Mark X.; O'Connell, Ed, Protein microspheres retaining pharmacokinetic and pharmacodynamic properties.
  156. Beaumont, Tim; Bakker, Adrianus Q.; Yasuda, Etsuko, RSV specific binding molecule.
  157. Beaumont, Tim; Bakker, Adrianus; Yasuda, Etsuko, RSV specific binding molecule.
  158. Beaumont, Tim; Bakker, Adrianus Q.; Yasuda, Etsuko, RSV-specific binding molecule.
  159. Spits, Hergen; Beaumont, Tim, RSV-specific binding molecules and means for producing them.
  160. Spits, Hergen; Beaumont, Tim; Kwakkenbos, Mark Jeroen; Yasuda, Etsuko, RSV-specific binding molecules and means for producing them.
  161. Spits, Hergen; Beaumont, Tim; Kwakkenbos, Mark Jeroen; Yasuda, Etsuko, RSV-specific binding molecules and means for producing them.
  162. Alessi, Thomas R.; Luskey, Kenneth, Rapid establishment and/or termination of substantial steady-state drug delivery.
  163. Rickey, Michael E.; Ramstack, J. Michael; Kumar, Rajesh, Residual solvent extraction method and microparticles produced thereby.
  164. Rickey, Michael E.; Ramstack, J. Michael; Kumar, Rajesh, Residual solvent extraction method and microparticles produced thereby.
  165. Rickey, Michael E.; Ramstack, J. Michael; Kumar, Rajesh, Residual solvent extraction method and microparticles produced thereby.
  166. Rickey, Michael E.; Ramstack, J. Michael; Kumar, Rajesh, Residual solvent extraction method and microparticles produced thereby.
  167. Rickey,Michael E.; Ramstack,J. Michael; Kumar,Rajesh, Residual solvent extraction method and microparticles produced thereby.
  168. Siegel, Steven; Winey, Karen, Risperidone-containing PLA:PGA implants and methods of use thereof.
  169. Siegel, Steven; Winey, Karen, Risperidone-containing implants and methods of use thereof.
  170. Oliver,Cynthia N.; Allan,Christian B.; Chang,Stephen T., Stabilized anti-respiratory syncytial virus (RSV) antibody formulations.
  171. Oliver, Cynthia N.; Shane, Erica; Isaacs, Benjamin S.; Allan, Christian B.; Chang, Stephen T., Stabilized liquid anti-RSV antibody formulations.
  172. Oliver, Cynthia N.; Shane, Erica; Isaacs, Benjamin S.; Allan, Christian B.; Chang, Stephen T., Stabilized liquid anti-RSV antibody formulations.
  173. Oliver, Cynthia N.; Shane, Erica; Isaacs, Benjamin S.; Allan, Christian B.; Chang, Stephen T., Stabilized liquid anti-RSV antibody formulations.
  174. Oliver, Cynthia N.; Shane, Erica; Isaacs, Benjamin S.; Allan, Christian B.; Chang, Stephen T., Stabilized liquid anti-RSV antibody formulations.
  175. Oliver, Cynthia N.; Shane, Erica; Isaacs, Benjamin S.; Allan, Christian B.; Chang, Stephen T., Stabilized liquid anti-RSV antibody formulations.
  176. Oliver, Cynthia N.; Shane, Erica; Isaacs, Benjamin S.; Allan, Christian B.; Chang, Stephen T., Stabilized liquid anti-RSV antibody formulations.
  177. Oliver, Cynthia N.; Shane, Erica; Isaacs, Benjamin S.; Allan, Christian B.; Chang, Stephen T., Stabilized liquid anti-RSV antibody formulations.
  178. Oliver,Cynthia N.; Shane,Erica; Isaacs,Benjamin S.; Allan,Christian B.; Chang,Stephen T., Stabilized liquid anti-RSV antibody formulations.
  179. Oliver,Cynthia N.; Shane,Erica; Isaacs,Benjamin S.; Allan,Christian B.; Chang,Stephen T., Stabilized liquid anti-RSV antibody formulations.
  180. Benatuil, Lorenzo; Boghaert, Erwin R.; Gu, Jijie; Harris, Maria; Hickson, Jonathan A.; Hsieh, Chung-Ming; Kutskova, Yuliya; Li, Yingchun; Liu, Zhihong; Morgan-Lappe, Susan, Therapeutic DLL4 binding proteins.
  181. Benatuil, Lorenzo; Boghaert, Erwin R.; Gu, Jijie; Harris, Maria; Hickson, Jonathan A.; Hsieh, Chung-Ming; Kutskova, Yuliya; Li, Yingchun; Liu, Zhihong; Morgan-Lappe, Susan, Therapeutic DLL4 binding proteins.
  182. Benatuil, Lorenzo; Boghaert, Erwin R.; Gu, Jijie; Harris, Maria; Hickson, Jonathan A.; Hsieh, Chung-Ming; Kutskova, Yuliya; Li, Yingchun; Liu, Zhihong; Morgan-Lappe, Susan, Therapeutic DLL4 binding proteins.
  183. Chen, Ming-Jiu; Hsieh, Chung-Ming; Gu, Jijie; Morgan-Lappe, Susan E.; Li, Yingchun, Therapeutic DLL4 binding proteins.
  184. Chen, Ming-Jiu; Hsieh, Chung-Ming; Gu, Jijie; Morgan-Lappe, Susan E.; Li, Yingchun, Therapeutic DLL4 binding proteins.
  185. Alessi, Thomas R.; Baron, Michelle, Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c.
  186. Arimura, Akira; Li, Min, Treatment of renal dysfunction and multiple myeloma using PACAP compounds.
  187. Young, James F.; Johnson, Leslie S.; Huse, William D.; Wu, Herren; Watkins, Jeffry D., Ultra high affinity neutralizing antibodies.
  188. Mueller, Bernhard K.; Macchi, Paolo; Bonhoeffer, Friedrich; Stahl, Bernd; Mann, Matthias; Andersen, Jens S.; Monnier, Philippe P., Use of RGM and its modulators.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로